04.02.2020 • NewsElaine BurridgeAzelis

Azelis Strengthens Indian Pharma Footprint

Azelis is to acquire S. Zhaveri Pharmakem, expanding its presence in India and gaining a significant footprint in the country’s fast-growing pharmaceutical market. Headquartered in Mumbai, S. Zhaveri serves both domestic and international principal suppliers to India’s pharmaceutical market.

Azelis Strengthens Indian Pharma Footprint (c) Azelis
Azelis Strengthens Indian Pharma Footprint (c) Azelis

The Belgian distributor said India is one of the world’s largest producers of pharmaceuticals, with strong growth potential that is attributed to its capabilities in chemical synthesis and formulation, increased accessibility and affordability, as well as market penetration into countries such as the US and other large regions.

“Azelis and S. Zhaveri’s distribution businesses are highly complementary,” said Aparna Khurana, managing director of Azelis India. “The Indian excipient market is outpacing the global growth rate. Here in India, we have favorable raw materials and labor environment coupled with quick adaptability of suppliers to new technology, which makes us a perfect and thriving ground for the industry.

“An acquisition in the pharma business is therefore a significant move for us, Khurana added. “We expect that the addition of S. Zhaveri will help us strengthen our relationship with some of our strategic principals and open up many new opportunities.”

The transaction is expected to close within the next few weeks. Financial details were not disclosed.

Azelis has been active in India since 2008 and runs application laboratories for food, personal care and coatings, adhesives, sealants and elastomers (CASE).

Just last month, subsidiary Azelis Americas closed its acquisition of Mexican specialty distributor Megafarma.

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

Photo
24.04.2025 • NewsBioprocessing

Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.